Cas no 62133-72-6 (Bartsiosid)
Bartsiosid Chemical and Physical Properties
Names and Identifiers
-
- Bartsiosid
- [(1S)-1β,4aβ,5,7aβ-Tetrahydro-7-(hydroxymethyl)cyclopenta[c]pyran-1-yl]β-D-glucopyranoside
- (2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-(((1S,4aR,7aS)-7-(hydroxymethyl)-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-1-yl)oxy)tetrahydro-2H-pyran-3,4,5-triol
- CHEMBL3622807
- Bartsioside, >=95% (LC/MS-ELSD)
- SCHEMBL2989887
- NCGC00169691-02
- NCGC00169691-01
- NCGC00169691-02_C15H22O8_(1S,4aR,7aS)-7-(Hydroxymethyl)-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-1-yl beta-D-glucopyranoside
- 62133-72-6
- ACon1_001085
- BRD-K86735058-001-01-2
- MEGxp0_001129
- (2S,3R,4S,5S,6R)-2-[[(1S,4aS,7aR)-7-(hydroxymethyl)-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-1-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
- Bartsioside
- (2S,3R,4S,5S,6R)-2-(((1S,4aS,7aR)-7-(hydroxymethyl)-1,4a,5,7a-tetrahydrocyclopenta(c)pyran-1-yl)oxy)-6-(hydroxymethyl)oxane-3,4,5-triol
- AS-87612
-
- MDL： MFCD29037214
- Inchi： 1S/C15H22O8/c16-5-8-2-1-7-3-4-21-14(10(7)8)23-15-13(20)12(19)11(18)9(6-17)22-15/h2-4,7,9-20H,1,5-6H2/t7-,9+,10+,11+,12-,13+,14-,15-/m0/s1
- InChI Key： FCHJZJFIDNMNBS-DNRYLMBSSA-N
- SMILES： O([C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)O)[C@H]1[C@H]2C(CO)=CC[C@H]2C=CO1
Computed Properties
- Exact Mass: 330.13146766g/mol
- Monoisotopic Mass: 330.13146766g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 5
- Hydrogen Bond Acceptor Count: 8
- Heavy Atom Count: 23
- Rotatable Bond Count: 4
- Complexity: 478
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 8
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: -1.9
- Topological Polar Surface Area: 129?2
Bartsiosid Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| XI GE MA AO DE LI QI （ SHANG HAI ） MAO YI Co., Ltd. | SMB00525-1MG |
Bartsioside |
62133-72-6 | 1mg |
￥3936.22 | 2023-09-13 |
Bartsiosid Related Literature
-
Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
-
Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
-
Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
-
Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
-
Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
Related Categories
- Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Prenol lipids Terpene glycosides Iridoid O-glycosides
- Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Prenol lipids Iridoid O-glycosides
- Natural Products and Extracts Plant Extracts Plant based Parentucellia viscosa
Additional information on Bartsiosid
Exploring Bartsiosid (CAS No. 62133-72-6): Properties, Applications, and Market Insights
Bartsiosid (CAS No. 62133-72-6) is a specialized chemical compound gaining attention in pharmaceutical and biochemical research. This naturally occurring glycoside belongs to a class of bioactive molecules known for their potential therapeutic properties. With the increasing demand for plant-derived compounds in modern medicine, Bartsiosid has emerged as a subject of interest for researchers exploring novel drug candidates and nutraceutical applications.
The molecular structure of Bartsiosid features a unique sugar moiety attached to an aglycone component, which contributes to its biological activity. Recent studies suggest that this compound may exhibit significant antioxidant and anti-inflammatory properties, making it particularly relevant in today's health-conscious market where consumers are actively searching for "natural anti-inflammatory compounds" and "plant-based antioxidants". These properties align with current trends in preventive healthcare and functional food development.
In pharmaceutical applications, Bartsiosid is being investigated for its potential role in metabolic regulation. Researchers are particularly interested in its possible effects on glucose metabolism, positioning it as a candidate for "natural diabetes management solutions". This aligns with the growing global concern about metabolic disorders and the search for alternative therapeutic approaches beyond conventional medications.
The compound's stability and solubility characteristics make it suitable for various formulation approaches. Pharmaceutical scientists are exploring its compatibility with different delivery systems, including "nanoparticle drug delivery" and "controlled-release formulations". These investigations are crucial as the industry moves toward more targeted and efficient drug delivery methods.
From a commercial perspective, the market for specialized glycosides like Bartsiosid is expanding. The global nutraceutical market, valued at over $400 billion, shows increasing demand for bioactive plant compounds. Market analysts note particular growth in segments searching for "natural cognitive enhancers" and "plant-derived neuroprotective agents", areas where Bartsiosid may have potential applications.
Quality control and standardization remain important considerations for Bartsiosid production. Advanced analytical techniques such as HPLC and mass spectrometry are employed to ensure purity and consistency, addressing the pharmaceutical industry's need for "high-purity botanical extracts". These quality measures are essential for regulatory compliance and therapeutic efficacy.
Current research trends focus on exploring Bartsiosid's mechanism of action at the molecular level. Scientists are particularly interested in its potential interactions with cellular signaling pathways, a topic frequently searched as "natural compound cell signaling". Understanding these mechanisms could unlock new therapeutic applications and enhance the compound's value in drug development.
Sustainability aspects of Bartsiosid production are also gaining attention. With growing consumer interest in "eco-friendly phytochemicals" and "sustainable sourcing of active ingredients", researchers are investigating cultivation methods and extraction processes that minimize environmental impact while maximizing yield and bioactivity.
In conclusion, Bartsiosid (CAS No. 62133-72-6) represents an intriguing compound at the intersection of traditional plant medicine and modern pharmaceutical science. Its diverse potential applications, from metabolic health to neuroprotection, coupled with the growing market for natural bioactive compounds, position it as a significant subject for ongoing research and commercial development. As scientific understanding of this compound deepens, we can anticipate new discoveries about its therapeutic potential and broader applications in health and wellness products.
62133-72-6 (Bartsiosid) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)
Audited Supplier
Audited Supplier
Audited Supplier
Audited Supplier
Audited Supplier
